2026-04-11T10:00:29Z https://pub.unibl.org/oai

oai:pub.unibl.org:40236 2024-06-12T14:22:23Z

Comparing biosimilar SB2 with reference infiximab after 54 weeks of a double-bilind trail:Clinical, structural and safety results /unibl/author/JS Smolen /unibl/author/JI Choe /unibl/author/Nenad Prodanović /unibl/author/J Niebrizidovski /unibl/author/I Staikov /unibl/author/E Dokoupilova /unibl/author/A Baranauskaite /unibl/author/R Iatsishin /unibl/author/M Mekić /unibl/author/V Poravska /unibl/author/H Ciferska /unibl/author/K Jedrichovicz-Rosiak /unibl/author/A Zelinska /unibl/author/I Lee /unibl/author/IH Rho 2017 Academic Article text 10 10 /unibl/sci/idNaucniRad:25129 RHEUMATOLOGY 1462-0324 https://pub.unibl.org/s/cir/item/40236